StockCall Pre-Market Review on Hologic, St. Jude Medical, ResMed, and Navidea Biopharma

StockCall Pre-Market Review on Hologic, St. Jude Medical, ResMed, and Navidea

PR Newswire

LONDON, March 15, 2013

LONDON, March 15, 2013 /PRNewswire/ --

Markets continued their ascent as The Dow Jones closed high for the tenth
consecutive day. Major indices including S&P and NASDAQ also ended the session
in the green zone. While a report alluded to the 'flare up' in housing
foreclosures, strong job data provided positive fillip to the markets.
However, with the sharp rise in the market, skepticism is also taking hold as
a leading financial expert Kerry Balenthiran warned that the markets may turn
bearish this year. Our research team took a look at Healthcare sector, more
specifically the Medical Appliances & Equipment industry which includes major
companies like Hologic Inc. (NASDAQ: HOLX), St. Jude Medical Inc. (NYSE: STJ),
ResMed Inc. (NYSE: RMD) and Navidea Biopharmaceuticals Inc. (NYSE: NAVB).
StockCall analysts initiated preliminary technical research on HOLX, STJ,
RMD, and NAVB. These free reports are accessible by signing today at

Hologic Inc. extended its 52 weeks gain by closing 0.99 percent higher. The
stock ended its Thursday session at $22.46, while its highest price point for
yesterday's session stood at $22.47. It traded 1.18 million shares, down from
its average daily volume high of 2.80 million. The medical equipment maker
traded in the range of $16.18 and $23.96 in the past 52 weeks and currently it
is trading near its high price point. The company commands market
capitalization of $6.01 billion and it reported its latest EPS at -$0.35.
Hologic Inc. stock gained more than 6 percent in the past 52 weeks. The free
technical analysis on HOLX is available by signing up at

St. Jude Medical Inc. slipped marginally with lower volume to end its latest
session at $42.90. The stock ended 0.21 percent lower than its previous close.
Its volume for the day stood at 2.15 million shares. The stock is currently
trading higher than its 20-day SMA of $42.89 but lower than its 50-day SMA of
$42.91, showing a neutral trend. Its first resistance level is at $43.05 while
it may tumble to $42.65 before receiving any support. St. Jude Medical's stock
is up 20.95 percent on a YTD basis, while offering 2.14 percent dividend
yield. Register now to download the free research on STJ at

ResMed Inc. ended yesterday's trading session at $43.74, up 0.81 percent from
its previous close. With its latest upward move, the stock is now up 6.92
percent on a YTD basis, while its 52 weeks gain stands at 45.9 percent. The
company oscillated in the range of $43.27 and $43.81 during Thursday's
session. It traded 958, 085 shares and showed a mild bullish trend. The stock
may touch $43.95 in the coming sessions. Upon breaching this level, its next
resistance level is at $44.25. Free report on RMD can be accessed by
registering at

Navidea Biopharmaceuticals Inc. sank in Thursday's session. The stock closed
7.91 lower at $2.91 with above average volume of 4.08 million shares, showing
a bearish trend. The company has its first support level at $2.75. Upon
breaching this level, its next support level is at $2.56. Navidea Biopharma is
currently trading near its 52 weeks low of $2.14, while its 52 weeks high
stands at $4.77. The company commands market capitalization of 312.51 million.
The company is also trading below its short-term and long-term average price,
further confirming a bearish trend. Register with StockCall and download the
research on NAVB for free at

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at 


Contact: Contact Person: William T. Knight, Email: ,
Contact Number: +1-(646)-396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.